Nabil F. Saba, MD, FACP, director of the Head and Neck Medical Oncology Program at Winship Cancer Institute of Emory University, professor in the Department of Hematology and Medical Oncology and Department of Otolaryngology at Emory University School of Medicine, discusses how the COVID-19 pandemic has impacted treatment in head and neck cancer and the health care system at large.

 to watch the entitreity of the MJH Life Sciences News Network, which provides the latest news across a variety of healthcare specialties, and a number of interviews with experts in the medical field, many of which are focused on the ongoing 

OncLive TV

® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers. 

Nabil F. Saba, MD, FACP, discusses how the COVID-19 pandemic has impacted treatment in head and neck cancer and the health care system at large.

Dr. Saba on Unique Set of Challenges Caused By COVID-19 in Head and Neck Cancer